CIM Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-18,635
| Closed | -$37K | – | 273 |
|
|
2020
Q2 | $37K | Buy |
18,635
+3,176
| +21% | +$6.31K | 0.01% | 252 |
|
|
2020
Q1 | $30K | Hold |
15,459
| – | – | 0.01% | 194 |
|
|
2019
Q4 | $64K | Sell |
15,459
-12,079
| -44% | -$50K | 0.03% | 234 |
|
|
2019
Q3 | $83K | Hold |
27,538
| – | – | 0.03% | 311 |
|
|
2019
Q2 | $173K | Sell |
27,538
-562
| -2% | -$3.53K | 0.06% | 305 |
|
|
2019
Q1 | $156K | Buy |
+28,100
| New | +$156K | 0.06% | 304 |
|
|
2018
Q4 | – | Sell |
-19,684
| Closed | -$210K | – | 318 |
|
|
2018
Q3 | $210K | Hold |
19,684
| – | – | 0.08% | 308 |
|
|
2018
Q2 | $236K | Sell |
19,684
-23,025
| -54% | -$276K | 0.08% | 312 |
|
|
2018
Q1 | $366K | Buy |
42,709
+26,973
| +171% | +$231K | 0.12% | 228 |
|
|
2017
Q4 | $155K | Sell |
15,736
-190
| -1% | -$1.87K | 0.05% | 318 |
|
|
2017
Q3 | $196K | Hold |
15,926
| – | – | 0.07% | 307 |
|
|
2017
Q2 | $262K | Buy |
+15,926
| New | +$262K | 0.09% | 302 |
|
|
2016
Q2 | – | Sell |
-22,753
| Closed | -$272K | – | 299 |
|
|
2016
Q1 | $272K | Buy |
+22,753
| New | +$272K | 0.12% | 212 |
|